Generic Name and Formulations:
Ticarcillin disodium 3g; IM or IV inj; sodium content 5.2–6.5mEq/g.
Various generic manufacturers
Indications for Ticarcillin:
Susceptible bacterial septicemia, respiratory or urinary tract, skin and soft tissue, gynecologic, intraabdominal infections.
UTI: 1g IM or IV every 6 hours. Systemic: 150–300mg/kg/day IV in divided doses every 4–6 hours. Max IM 2g per inj. In more severe infections use higher doses by IV route.
Neonates <2kg: 75mg/kg every 12 hours until 7 days old, then 75mg/kg every 8 hours. >2kg: 75mg/kg every 8 hours until 7 days old, then 100mg/kg every 8 hours. Others <40kg: UTI: 50–100mg/kg/day IM or IV in divided doses every 6–8 hours. Systemic: 150–300mg/kg/day IV in divided doses every 4–6 hours. >40kg: as adult.
Cephalosporin, imipenem, or other allergy: not recommended. Renal impairment, reduce dose (see literature) and monitor for bleeding disorders. Heart disease. Sodium restricted diets. Monitor serum electrolytes (esp. potassium) and renal, hepatic, hematopoietic function during prolonged therapy. Pregnancy.
Potentiated by probenecid.
Inj site reactions, rash, pruritus, drug fever, GI upset, blood dyscrasias, hemorrhage, hypokalemia, anaphylaxis, CNS stimulation, elevated liver enzymes.
Formerly known under the brand name Ticar.